A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

Clinical trial NCT05232461 · COMPLETED

Trial details

NCT number: NCT05232461
Sponsor: NeuroSense Therapeutics Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2022-04-08
Primary completion: 2022-04-21
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.